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IntrOductIOn
Otitis externa is the inflammation of external ear canal. 
Epidemiologically, the prevalence is four in every thousand 
children and/or adults per year, of which 80% occurs in summer 
[1]. The most common bacterial causes of ear infections include 
Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus 
pyogenes and some coliform bacteria [2,3].
Treatment of this disease may be simple and it is cured in one visit 
[4], but sometimes it is likely to be life-threatening and has fatal 
complications. In most cases, the treatment is topical therapy [1]. 
Several drugs have been used for topical treatment of the disease. 
Some of these drugs are neomycin and hydrocortisone ear drops 
or ciprofloxacin drops [5].
Another drug that is locally used in the treatment of acute otitis 
externa is combination drug of polymyxin B, neomycin and 
hydrocortisone or polymyxin NH [6]. Of other drugs used in the 
treatment of this disease is the solution of boric acid in ethylic 
alcohol 95% or that of acetic acid 2% [7].
There is no agreement upon the use of prescribed drugs in the 
treatment of acute otitis externa and different drugs have been 
introduced in various reference books for its treatment but none 
of them has been identified as the drug of choice because no 
significant difference has been reported in the effectiveness of drug 
treatments. One of the compounds widely used in the treatment 
of acute otitis externa is polymyxin NH combination, although this 
combination is effective in many external otitis, but it can trigger 
some complications. For example, neomycin and polymyxin can 
 
be ototoxic in patients with perforated tympanic membrane and 
cause damage to the inner ear. On the other hand, neomycin is 
the most common drug that causes contact dermatitis in the outer 
ear [4].
Polymyxin NH is relatively expensive. Another drug that has been 
used in the treatment of otitis externa is boric acid and no specific 
side effect has been reported for it [6,7]. It is a cheaper drug than 
polymyxin NH thus important in terms of reducing health care 
costs for patients.
In addition, one of the predisposing factors of fungal otitis externa 
is the history of local antibiotics intake. As boric acid is a drug 
that not only prevents fungal otitis externa but also is effective 
in treatment of it. Regarding the epidemiological differences in 
response to treatment with these drugs in patients, this study 
could be helpful in determining which drug is more effective for 
patients in this region. 
AIm
The aim of this study was to compare the effect of boric acid 
and polymyxin, neomycin and hydrocortisone compound in the 
treatment of acute otitis externa. 
mAterIAls And methOds
This double blind clinical trial study was carried out in 2013. A total 
of 80 patients aged more than 17 years old were included. The 
IRCT code of this study is 201409256252N6. The patients were 
selected among those who were referred to Kashani hospital clinic 
with a diagnosis of acute otitis externa by otolaryngologist.
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Comparison of Boric Acid and 
Combination Drug of Polymyxin, Neomycin 
and Hydrocortisone (polymyxin NH) in the 
Treatment of Acute Otitis Externa
SorouSh AmANi1, mohAmmAd moEiNi2 
ABstrAct
Introduction: Acute otitis externa is an inflammation of the 
external auditory canal known as "swimmer's ear". Direct costs 
including medical treatment, painkillers, antibiotics, steroids or 
both and indirect costs are also remarkable. 
Aim: The aim of this study was to compare the effect of boric 
acid and polymyxin, neomycin and hydrocortisone composition 
in the treatment of acute otitis externa.
materials and methods: This randomized clinical trial was 
carried out on 80 patients aged more than 17-year-old who 
were referred to Kashani hospital clinic with a diagnosis of acute 
otitis externa by otolaryngologist. The patients were randomly 
allocated to two groups (A: Boric acid and B: polymyxin NH ear 
drops) and Painkiller was prescribed and administered orally for 
all patients and in the presence of fever, cellulitis around the 
ears and neck adenopathy, broad-spectrum systemic antibiotics 
were used besides topical treatment. Symptoms of patients who 
were evaluated by a physician includes pain, discharge from 
the ear, swelling of the ear canal, auricle swelling, tenderness, 
and ear itching. In addition, pain was evaluated in patients and 
was recorded by Macgill Pain Questionnaire, in the first, third, 
seventh and tenth days. 
results: Results showed that itching on third day (p=0.007) and 
swelling of the ear canal in the examination of the third day 
(p=0.006) and the seventh day (p=0.001) in the polymyxin NH 
group was more than those of boric acid group. Overall mean 
pain based on McGill questionnaire was 11.10±1.49 in boric 
acid group in the examination on the first day and was 4.05±0.22 
in the examination on the tenth day and in the polymyxin NH 
group, it was 10.9±0.99 on the first day and 4.20±0.40 on the 
tenth day. In both groups, pain relief was the same and there 
was no significant difference between two groups (p=0.075).
conclusion: The findings of this study showed slight differences 
in the effectiveness of the boric acid drug and combination of 
polymyxin, neomycin and hydrocortisone in the treatment of 
patients with acute otitis externa that is of clinical significance. 
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stAtIstIcAl AnAlysIs
After completing the questionnaires, the data were analysed through 
SPSS software 17.0. Mean, standard deviation and frequency 
distribution data were analysed using descriptive statistics and 
correlation between variables in 2 groups were analysed using 
independent t-test (age) and chi square (sex). Besides, to compare 
the clinical symptoms in the 2 groups, the chi-square test and to 
compare criteria of McGill pain questionnaire in two groups, Mann-
Whitney test was used with respect to non-normality of the data. 
results
In this study, the age of patients in the first group (BA) ranged 
between 19 and 65 years with a mean and standard deviation of 
43.3 ± 15.11 respectively and was in the range of 21 to 63 years 
with a mean and standard deviation of 45.45 ± 12.7 in the second 
group (pNH group). According to independent t-test, no significant 
difference was observed between the two groups in terms of age 
of subjects (p=0.102). In the first group, 45% (n = 18) were female 
and 55% (n=22) were male and in the second group, 60% (n=24) 
were female and 40% (n=16) were male. The chi-square test 
showed no significant difference between the groups in terms of 
sex (p =0.179). The results of the statistical analysis of patients’ 
symptoms during examination on days zero, third, seventh and 
tenth in two groups is shown in [Table/Fig-1].
Ear discharge was reported more in the BA group than the PNH 
group at the baseline examination (p=0.012). Itching on the first (p 
=0.011) and the third day of examination (p=0.007) was more in 
the second group than the first group and swelling of ear canal in 
the examination on the third day (p=0.006) and seventh day was 
more in the PNH group (p=0.001) than the BA group. 
Regarding the four criteria of assessment of pain, on the first 
and third days of examination, there was no significant difference 
between the two groups (p≥0.05). On the seventh day, no 
significant difference was observed between the scores of 
examination criteria (p=0.001) and evaluation criteria (p=0.041), 
thus, the severity of pain were reported less in BA group than PNH 
group regarding to the examination criteria and evaluation criteria. 
On the tenth day of examination, descriptive criteria (p=0.044) 
between the two groups showed significant difference. So, in the 
case of descriptive criteria, the severity of pain was reported less 
in BA group compared with PNH group [Table/Fig-2]. Overall pain 
severity on the seventh day (p =0.001) and the tenth day (p=0.044) 
in BA group were reported less than that of PNH group. 
dIscussIOn
Otitis externa is one of the most common types of ear infection and 
is estimated to be present between 5-20 percent of all patients 
with ENT (ear, nose, throat) problems [12]. Topical antibiotic 
treatment is very effective for improvement of patients with acute 
otitis externa. It is reported that, about 15% of patients with acute 
otitis externa recover without receiving any treatment within 10 
days i.e. recovery rate is increased 65 to 80% with the use of 
topical antibiotics, steroids, or both [13].
Regarding the findings of this study, clinical symptoms of patients 
were more reduced in BA group as compared to polymyxin, 
neomycin, and hydrocortisone group. Clinical trials that assessed 
symptoms of patients after topical treatment, concluded that ear 
pain after just one day of treatment was significantly decreased in 
patients and most of the symptoms including itching, ear discharge 
were improved after 4 and 7 days [14-16].
Previous studies suggested that hydrocortisone addition to acetic 
acid significantly reduce ear pain from 8 days to 7 days [14].
Besides, adding hydrocortisone to ciprofloxacin compared with 
the combination of neomycin, polymyxin B and hydrocortisone 
can reduce ear pain from the period of 4.7 days to 3.8 days [17].
Inclusion criteria of this study were, male and female patients aged 
more than 17 years old with a diagnosis of acute otitis externa. 
Exclusion criteria included treatment with topical treatment 
within the last two weeks or received oral antibiotics, diabetic 
patients, people with immunodeficiency, those who received oral 
corticosteroids or immunosuppressive drugs, patients who had 
perforated eardrum, those whose external otitis lasted more than 
three weeks and patients with furunculous of external ear canal. 
After that eligible patients were diagnosed according to inclusion 
and exclusion criteria, written consent forms were distributed 
among the participants by doctor’s physician. All participants 
signed consent forms. Finally, information of about 80 patients 
was analysed. 
In this study, patients were randomly divided into two groups based 
on the even and odd numbers of reception, or based on their turn 
of examination that was in odd and even days and interventions 
were conducted by a colleague. The first group was given boric 
acid 3%, and the second group was given polymyxin NH ear 
drops. The dosage for both the groups was, three drops into the 
ear canal, three times a day. For all patients, oral palliative were 
prescribed and administered. In the case of fever, cellulitis around 
the ears and neck lymphadenopathy, broad-spectrum systemic 
antibiotics was used alongside topical therapy [8]. In the first visit, 
the patients were examined by an otolaryngologist. Symptoms that 
were recorded were as follows: pain, ear discharge, the inflamed 
ear canal, auricle swelling. Tenderness was recorded based on 
the severity of symptoms in McGill Pain questionnaire that has 
acceptable validity and reliability. The subsequent examination 
was done on the days 3, 7 and 10. Furthermore, patients were 
asked at each visit for the presence of symptoms such as itching 
and hearing loss and the presence or absence of cellulite around 
the ears. Cervical lymphadenopathy and fever were also recorded 
at each visit. In patients suffering from severe inflammation of the 
ear canal so that the drug was unable to reach the ear canal, 
cotton wick dipped in anti-inflammatory ointment was used and 
was placed inside the ear canal and in the second visit, the wick 
was removed and if necessary, another cotton wick was re-laid. In 
the case of presence of discharge inside the ears canal, it removed 
from the ear canal for all patients at each visit.
This research was a double-blind study, i.e., neither the patients 
nor the researchers were aware of the medications prescribed. 
Drug drops were packaged identically and were tagged by 
pharmacologist and were separated from each other. A researcher-
designed questionnaire were used to gather data like age, sex, 
clinical symptoms consisting of ear discharge, pain, tenderness, 
itching, hearing loss, the inflamed ear canal, auricle swelling, 
cellulitis, neck lymphadenopathy, fever. The first part of McGill 
questionnaire was also used in gathering information.
The first part of the questionnaire consisted of four criteria: the 
Descriptive criterion [description of pain by the patient), evaluation 
criterion (evaluation of patient conditions and the limitations that 
the pain has caused in his life), behavioural criterion (change that 
pain has caused in his behaviour], examination criterion (clinical 
examination was done by a physician). The first three criteria was 
scored from 0 to 5 and the last criterion i.e. examination criterion 
was from 0 to 3. Thus, the score of the first part was between 0 
and 18.
This questionnaire was first used by Melzack (1973) on 297 
patients who suffered from various types of pain [9]. After numerous 
studies and research, this questionnaire was introduced and 
recommended as a reliable tool for research and pain assessment 
with various clinical methods.
Besides, Ibrahim Nejad et al., examined the validity and reliability 
of this questionnaire in Iran and were shown its Cronbach's alpha 
coefficient equal to 90, indicating that this questionnaire is of high 
reliability [10,11].
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Group variable First group Second group p-value 
(chi-
square 
test)
Absolute 
frequency
relative 
frequency
Absolute 
frequency
relative 
frequency
Ear 
discharge
first day 
examination
34 85 24 60 0.012
third day 
examination
12 30 14 35 0.63
seventh day 
examination
4 10 4 10 1
tenth day 
examination
0 0 0 0
Itching first day 
examination
34 85 40 100 0.011
third day 
examination
16 40 28 70 0.007
seventh day 
examination
4 10 10 25 0.077
tenth day 
examination
0 0 0 0
Hearing 
loss
first day 
examination
30 75 32 80 0.59
third day 
examination
2 5 2 5 1
seventh day 
examination
0 0 0 0
tenth day 
examination
0 0 0 0
Swelling 
ear canal
first day 
examination
38 95 38 95 1
third day 
examination
18 45 30 75 0.006
seventh day 
examination
0 0 16 40 0.001
tenth day 
examination
0 0 0 0
Auricle 
swelling
first day 
examination
2 5 5 5 1
third day 
examination
0 0 0 0
seventh day 
examination
0 0 0 0
tenth day 
examination
0 0 0 0
Fever first day 
examination
2 5 0 0 0.15
third day 
examination
0 0 0 0
seventh day 
examination
0 0 0 0
tenth day 
examination
0 0 0 0
Pain first day 
examination
6 15 6 15 1
third day 
examination
0 0 0 0
seventh day 
examination
0 0 0 0
tenth day 
examination
0 0 0 0
[table/Fig-1]: Absolute and relative frequency of patients’ symptoms in both groups 
(boric acid and combination of polymyxin, neomycin hydrocortisone)
steroids, the second group combined antibiotics, steroids as 
well as antifungal agent and the third group received boric acid 
in alcohol. The results indicated that solutions with antibiotics 
have no superiority over boric acid in the treatment of acute 
otitis externa [20]. Based on the results, there was no significant 
difference in the first and third days, but after seven days, pain was 
significantly reported lower in the first group. After 10 days, the 
descriptive criteria in the first group were significantly less than the 
second group. The severity of pain decreased from 11.10±1.4 in 
the first group to 4.05±0.22 on the tenth day in the first group and 
in the second group, it decreased from 10.90±0.99 to 4.20±0.40. 
Changes in the reduction of pain in the first group was more than 
those of the second group, but this difference was not significant 
between the two groups (p =0.075).
In another study, ciprofloxacin plus dexamethasone was more 
effective in reducing pain in patients with acute otitis externa and it 
reduced the severity of pain much faster after initiation of treatment 
[21]. Besides, Kantas stated in his study that trichloroacetic acid 
5% (TCA) had more efficacy, fewer side effects and better pain 
relief as well as significant impact in preventing relapse compared 
with combination of antibiotics and steroids in the treatment of 
acute otitis externa [22].
In the study of Psifidis, full recovery of otitis externa was reported 
in patients treated with polymyxin NH, with ciprofloxacin and 
hydrocortisone and with ciprofloxacin alone as 84%, 100%, 96.7% 
respectively [8]. In a study by Mendelsohn, the effect of topical 
boric acid, acetic acid and placebo on otitis externa in dogs was 
evaluated, and it was shown that boric acid significantly reduced 
fungal organisms compared to acetic acid and placebo in dogs 
[19].
cOnclusIOn
As observed in the study, the effect of boric acid in recovery of 
symptoms and pain relief in patients with acute otitis externa in 
Similarly, in studies comparing neomycin, polymyxin and 
hydrocortisone, antiseptic alone significantly reduced duration of 
symptoms from 11.1 days to 9/4 days [18] and decreased average 
days of inflammation from 7.4 to 5/6 [19].
In a study by Slack and colleagues on 27 patients with primary 
diagnosis of otitis externa who did not receive any topical treatment 
in the last two weeks, three treatment methods were compared 
with each other. One group was a combination of antibiotics and 
Group Boric acid polymyxin, 
neomycin and 
hydrocortisone
p-value
variable Exami-
nation 
day
mean ± 
Standard    
deviation
mean ± 
Standard 
deviation 
Pain 
assessment 
criteria
Descriptive 
criteria
first 0.57±3.35 3.15±0.48 0.08
third 0.30±2.1 2.20±0.40 0.213
seventh 0.36±1.85 2±0.32 0.056
tenth 0.22±1.05 1.2±0.40 0.044
Examination
criteria
first 0.64±2.70 2.60±0.49 0.319
third 0.22±1.95 2±0 0.155
seventh 0.30±1.1 1.55±0.50 0.001
tenth 0±1 0±1 1
Evaluation
criteria
first 0.46±2.70 2.70±0.46 1
third 0.50±1.50 1.60±0.49 0.372
seventh 0±1 1.1±0.30 0.041
tenth 0±1 0±1 1
Behavioral 
criteria
first 0.57±2.35 2.35±0.48 0.87
third 0.46±1.30 1.45±0.50 0.169
seventh 0±1 1±0 1
tenth 0±1 0±1 1
Overall pain first 11.10±1.4 10.90±0.99 0.06
third 1.02±6.85 0.19±7.25 0.185
seventh 0.50±4.95 0.80±5.65 0.001
tenth 4.05±0.22 4.20±0.40 0.044
[table/Fig-2]: Mean and standard deviation of criteria of McGill pain questionnaire in 
BA and PNH in the examination on the first day to the tenth day.
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comparison with polymyxin, neomycin hydrocortisone, the use 
of boric acid is suggested in the treatment of these patients. 
Boric acid is a mild acid and is mostly used as a disinfectant in 
inflammation including inflammation of the external ear canal. It 
does not have antibiotics component, so, there is no concern for 
predisposition to antibiotic resistance. Hence, it is recommended 
to use this drug in patients with acute otitis externa.
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